Marine Biotechnology in Austria
Overarching science strategies, plans and policies
Research funding schemes and programmes
Research priorities for marine biotechnology research
- Several higher level strategic documents area available on the website of the Austrian Council for Research and Technology Development . These include:
- Strategy 2020 – Research, Technology and Innovation for Austria
- Strategy for Excellence; Strategy 2010 – Perspectives for Research, Technology and Innovation in Austria
- National Research and Innovation Plan
Infrastructures and coordination and support capacities / initiatives
- There are a number of online databases and directories which provide information about biotech and life science research activities including:
- The Austrian Centre of Industrial Biotechnology groups several research actors active in the industrial biotechnology sector in Austria. It plans to make the development of bioprocesses more transparent, predictable and thus faster, calculable and cheaper.
- The Research Centre Applied Biocatalysis is involved in the Austrian Centre of Industrial Biotechnology. It aims to focus the expertise of all partners to form a Research Centre for Applied Biocatalysis with sustained international and national competitiveness that forms an attractive platform for applied biocatalysis.
While Austria might not be an obvious location for marine biotechnology, several companies and research institutes include an important focus on marine biotechnology research. Notable examples are:
- Sealife Pharma® . The mission of the company is to discover and develop new active substances of marine origin to successfully treat infections caused by multi-drug resistant pathogens in the future.
This draft country profile is based on available online information sources and contributions from various country experts and stakeholders. It does not aim nor claim to be complete or final, but should be considered as a dynamic and living information resource that will be elaborated, updated and improved as more information becomes available, including further inputs from experts and stakeholders.
The information on this page is based on information initially compiled by the European Marine Board as part of the CSA MarineBiotech Project activities (2011-2013).